While
other EU Member States, notably England and Scotland,
have established single HTA agencies for the purpose of
conducting cost-effectiveness and cost utility evaluations,
France, at the time of interview, conducted HTA across
a network of government agencies, none of which actually engaged in either cost-effectiveness analysis, or any
other direct form of economic evaluation, but all of which
played important roles in operating a range of mechanisms
for containing healthcare spending.